Biodesix, Inc.
News
Biodesix to Present at Two Investor Conferences in September
Business Wire Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that members of the Biodesix management team will present at two upcoming investor...\n more…
Biodesix, Inc. (NASDAQ:BDSX) Sees Significant Decrease in Short Interest
Ticker Report Biodesix, Inc. (NASDAQ:BDSX - Get Free Report) was the recipient of a significant decrease in short interest in the month of August. As of August 15th, there was short interest totalling 423,500...\n more…
Biodesix, Inc. (NASDAQ:BDSX) Receives Consensus Recommendation of "Buy" from Analysts
Zolmax Shares of Biodesix, Inc. (NASDAQ:BDSX - Get Free Report) have been assigned a consensus recommendation of "Buy" from the six research firms that are covering the company, MarketBeat.com reports. Six...\n more…
Biodesix, Inc. (NASDAQ:BDSX) Receives $3.08 Consensus Price Target from Brokerages
Ticker Report Shares of Biodesix, Inc. (NASDAQ:BDSX - Get Free Report) have earned a consensus rating of "Buy" from the six ratings firms that are currently covering the stock, Marketbeat.com reports. Six analysts...\n more…
William Blair Comments on Biodesix, Inc.'s Q3 2024 Earnings (NASDAQ:BDSX)
Ticker Report Biodesix, Inc. (NASDAQ:BDSX - Free Report) - Analysts at William Blair decreased their Q3 2024 EPS estimates for Biodesix in a research note issued on Thursday, August 8th. William Blair analyst A...\n more…